44.6% of the levetiracetam treated patients and 19.6% of the patients on placebo had a 50% or greater reduction from baseline in the partial onset seizure frequency per week.
44, 6% levetiratsetaamiga ravitud patsientidel ning 19, 6% platseebogrupi patsientidel täheldati partsiaalsete krambihoogude iganädalase esinemissageduse 50% - list või enamat vähenemist.